全球腦癌診斷市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢和預測

全球腦癌診斷市場需求預計將從 2022 年的 25 億美元增至 2030 年的近 42.6 億美元，2023-2030 年研究期間CAGR為 6.9%。

腦癌診斷涉及透過各種醫療程序、測試和影像技術來識別、評估和確定腦腫瘤或癌症。這些診斷對於準確診斷腦腫瘤、確定其特徵、位置和大小以及對癌症嚴重程度進行分級至關重要。

市場動態：

腦癌診斷市場的成長受到技術進步、疾病發生率上升和醫療保健意識等多種因素的推動。成像技術的進步推動了對更精確和早期檢測能力的需求。全球腦腫瘤盛行率的不斷上升增加了對準確診斷工具和程序的需求，以促進早期發現和及時介入。提高認知活動和篩檢措施進一步推動了高風險族群對診斷測試的需求。活體組織切片技術和基因檢測的技術創新有助於更精確地表徵腫瘤，有助於個人化治療方法。此外，對非侵入性診斷方法的偏好促進了侵入性較小的技術的發展。政府支持、研究資助以及診斷公司和醫療機構之間的合作促進了先進腦癌診斷解決方案的創新和發展。總的來說，這些因素推動了腦癌診斷市場的成長，促進創建更有效、患者友善的診斷工具，用於早期檢測和客製化治療策略。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球腦癌診斷市場的每個細分市場進行了包容性評估。腦癌診斷產業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲腦癌診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。腦癌診斷市場的主要參與者包括 GE Healthcare、Siemens Healthineers、Philips Healthcare、Thermo Fisher Scientific、Rare Diagnostics、Abbott Laboratories、Illumina Inc、Hologic Inc、Agilent Technologies、Bio Rad Laboratories。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：腦癌診斷 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 透過診斷技術進行市場吸引力分析
  • 按腦癌類型分類的市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球腦癌診斷市場分析：按診斷技術

• 診斷技術概述
• 歷史和預測數據
• 診斷技術分析
• 影像技術（磁振造影 (MRI)、電腦斷層掃描 (C1) 掃描、PET 掃描或 PE CT 掃描、單光子發射電腦斷層掃描 (SPECT) Scat）
• 組織取樣/活體組織切片
• 分子診斷
• 其他

第 6 章：全球腦癌診斷市場分析：按腦癌類型

• 腦癌類型概述
• 歷史和預測數據
• 依腦癌類型分析
• 神經膠質瘤
• 腦膜瘤
• 腦下垂體腫瘤
• 其他

第 7 章：全球腦癌診斷市場分析：依最終用戶分類

• 最終用戶概述
• 歷史和預測數據
• 最終用戶分析
• 醫院
• 診斷實驗室
• 癌症醫院/中心

第 8 章：全球腦癌診斷市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：腦癌診斷公司的競爭格局

• 腦癌診斷市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 公司股份分析
• 市場集中度
• GE Healthcare
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Siemens Healthineers
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Philips Healthcare
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Thermo Fisher Scientific
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Rare Diagnostics
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Abbott Laboratories
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Illumina Inc
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Hologic Inc
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Agilent Technologies
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bio Rad Laboratories
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Brain Cancer Diagnostics Market is presumed to reach the market size of nearly USD 4.26 BN by 2030 from USD 2.5 BN in 2022 with a CAGR of 6.9% under the study period 2023 - 2030.

Brain cancer diagnostics involve the identification, assessment, and determination of brain tumors or cancers through various medical procedures, tests, and imaging techniques. These diagnostics are crucial in accurately diagnosing brain tumors, determining their characteristics, location, and size, and grading the cancer's severity.

MARKET DYNAMICS:

The brain cancer diagnostics market experiences growth propelled by diverse factors at the intersection of technological advancements, rising disease incidence, and healthcare awareness. Advancements in imaging technologies drive the demand for more precise and early detection capabilities. The increasing prevalence of brain tumors worldwide amplifies the need for accurate diagnostic tools and procedures to facilitate early detection and timely intervention. Heightened awareness campaigns and screening initiatives further drive the demand for diagnostic tests among at-risk populations. Technological innovations in biopsy techniques and genetic testing contribute to more precise tumor characterization, aiding in personalized treatment approaches. Moreover, the preference for non-invasive diagnostic methods fosters the development of less invasive techniques. Government support, research funding, and collaborations between diagnostic firms and healthcare institutions foster innovation and the development of advanced brain cancer diagnostic solutions. Collectively, these factors fuel the growth of the brain cancer diagnostics market, promoting the creation of more effective, patient-friendly diagnostic tools for early detection and tailored treatment strategies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of brain cancer diagnostics. The growth and trends of brain cancer diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the brain cancer diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnostic Technique

• Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat)
• Tissue Sampling/Biopsy
• Molecular Diagnostics
• Others

By Brain Cancer Type

• Gliomas
• Meningiomas
• Pituitary Tumors
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Cancer Hospitals/Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Brain Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Brain Cancer Diagnostics market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Thermo Fisher Scientific, Rare Diagnostics, Abbott Laboratories, Illumina Inc, Hologic Inc, Agilent Technologies, Bio Rad Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . BRAIN CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Diagnostic Technique
  • 3.7.2 Market Attractiveness Analysis By Brain Cancer Type
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSTIC TECHNIQUE

• 5.1 Overview by Diagnostic Technique
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Diagnostic Technique
• 5.4 Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Historic and Forecast Sales by Regions
• 5.5 Tissue Sampling/Biopsy Historic and Forecast Sales by Regions
• 5.6 Molecular Diagnostics Historic and Forecast Sales by Regions
• 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY BRAIN CANCER TYPE

• 6.1 Overview by Brain Cancer Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Brain Cancer Type
• 6.4 Gliomas Historic and Forecast Sales by Regions
• 6.5 Meningiomas Historic and Forecast Sales by Regions
• 6.6 Pituitary Tumors Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Hospitals Historic and Forecast Sales by Regions
• 7.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
• 7.6 Cancer Hospitals/Centers Historic and Forecast Sales by Regions

8 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BRAIN CANCER DIAGNOSTICS COMPANIES

• 9.1. Brain Cancer Diagnostics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF BRAIN CANCER DIAGNOSTICS INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. GE Healthcare
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Siemens Healthineers
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Philips Healthcare
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Thermo Fisher Scientific
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Rare Diagnostics
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Abbott Laboratories
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Illumina Inc
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Hologic Inc
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Agilent Technologies
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Bio Rad Laboratories
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Diagnostic Technique (USD MN)
• Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Market Sales by Geography (USD MN)
• Tissue Sampling/Biopsy Market Sales by Geography (USD MN)
• Molecular Diagnostics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Brain Cancer Type (USD MN)
• Gliomas Market Sales by Geography (USD MN)
• Meningiomas Market Sales by Geography (USD MN)
• Pituitary Tumors Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Diagnostic Laboratories Market Sales by Geography (USD MN)
• Cancer Hospitals/Centers Market Sales by Geography (USD MN)
• Global Brain Cancer Diagnostics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Brain Cancer Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Brain Cancer Diagnostics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Diagnostic Technique
• Market Attractiveness Analysis by Brain Cancer Type
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Diagnostic Technique (USD MN)
• Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Market Sales by Geography (USD MN)
• Tissue Sampling/Biopsy Market Sales by Geography (USD MN)
• Molecular Diagnostics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Brain Cancer Type (USD MN)
• Gliomas Market Sales by Geography (USD MN)
• Meningiomas Market Sales by Geography (USD MN)
• Pituitary Tumors Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Diagnostic Laboratories Market Sales by Geography (USD MN)
• Cancer Hospitals/Centers Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.